WHO Ordinal Scale and Inflammation Risk Categories in COVID-19. Comparative Study of the Severity Scales. J Gen Intern Med. 2022 Apr 8:1–8. doi: 10.1007/s11606-022-07511-7. Epub ahead of print. PMID: 35396659; PMCID: PMC8992782.F.I.:5.13
The importance of association of comorbidities on COVID-19 outcomes: a machine learning approach. Curr Med Res Opin. 2022 Apr;38(4):501-510. doi: 10.1080/03007995.2022.2029382. Epub 2022 Feb 1. PMID: 35037799.F.I.:2.58
Pre- and in-hospital anticoagulation therapy in coronavirus disease 2019 patients: a propensity-matched analysis of in-hospital outcomes. J Cardiovasc Med (Hagerstown). 2022 Apr 1;23(4):264-271. doi: 10.2459/JCM.0000000000001284. PMID: 34878430.F.I.:2.16
Juvenile Hemochromatosis due to a Homozygous Variant in the HJV Gene. Case Rep Pediatr. 2022 Apr 11;2022:7743748. doi: 10.1155/2022/7743748. PMID: 35449524; PMCID: PMC9017560.F.I.:
European association for clinical pharmacology and therapeutics young clinical pharmacologists working group: a cornerstone for the brighter future of clinical pharmacology. Eur J Clin Pharmacol. 2022 Apr;78(4):691-694. doi: 10.1007/s00228-022-03277-3. Epub 2022 Jan 17. PMID: 35037981; PMCID: PMC8761867.F.I.:2.95
SURGICAL TREATMENT OF LIVER HYDATID CYST IN ELDERLY PATIENTS: A PROPENSITY SCORE-MATCHING RETROSPECTIVE COHORT STUDY. Acta Trop. 2022 Apr 20:106466. doi: 10.1016/j.actatropica.2022.106466. Epub ahead of print. PMID: 35460646.F.I.:3.11
Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss. Am J Transplant. 2022 Apr;22(4):1169-1181. doi: 10.1111/ajt.16899. Epub 2021 Dec 21. PMID: 34856070.F.I.:8.09.
GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases
Isabel Jaén Torrejimeno del Servicio de Cirugía General y Aparato Digestivo del Complejo Hospitalario Universitario de Badajoz , participa en el articulo. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases. GECOP-MMC es un ensayo clínico […]
Workplace interventions to reduce the risk of SARS‐CoV‐2 infection outside of healthcare settings. Review 2022
Pizarro AB, Persad E, Durao S, Nussbaumer-Streit B, Engela-Volker JS, McElvenny D, Rhodes S, Stocking K, Fletcher T, Martin C, Noertjojo K, Sampson O, Verbeek JH, Jørgensen KJ, Bruschettini M. Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings. Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No.: CD015112. Leer […]
Viñeta del ECA PROfound [Olaparib + Estándar] vs [Estandar] en cáncer de próstata.
Marta González Cordero del Servicio de Oncología Médica del Complejo Hospitalario Universitario de Badajoz , ha elaborado Viñeta del ECA PROfound [Olaparib + Estándar] vs [Estandar] en cáncer de próstata. Ensayo aleatorizado, controlado, multicéntrico, abierto, estratificado por uso previo de taxanos (sí vs no) y por enfermedad medible (sí vs no). La variable principal fue […]